Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-27

Clinical Trial Update: Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chronic Pain After Thoracoscopic Pneumonectomy: A Multicenter, Randomized, Double-blind, Controlled Clinical Trial [Phase 4]

View source ↗

Summary

Phase 4 multicenter randomized trial evaluating liposomal bupivacaine for paravertebral nerve block to treat acute and chronic postoperative pain after thoracos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine) (liposomal bupivacaine)

Snippet

Sponsor: The Second Affiliated Hospital of Chongqing Medical University | Conditions: Acute Pain, Chronic Pain | Phase 4 | Status: RECRUITING